XSAU
1212
Market cap3.06bUSD
Nov 12, Last price
143.50SAR
Name
Astra Industrial Group Company SJSC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Astra Industrial Group Company, through its subsidiaries, engages in the pharmaceuticals, specialty chemicals, power and steel, mining, and other businesses in the Kingdom of Saudi Arabia, Africa, the United States, Asia, Europe, and internationally. The company develops, manufactures, markets, and distributes branded generic and under-licensed pharmaceuticals products in various therapeutic areas, including CNS, cardiovascular, anti-infective, respiratory, and muscular skeletal system; and produces masterbatches, dust-free additives, and custom-made thermoplastic compounds, and liquid and paste colorants for polymer manufacturing and converting, and plastic processing industries. It also manufactures, imports, and distributes a range of agrochemicals, fertilizers, public health and veterinary pesticides, seeds, and other agricultural inputs; and produces pre-engineered steel buildings and steel structures, as well as steel billets and rebars for the construction industry. In addition, the company explores for ores and minerals. Further, it builds, operates, manages, and invests in industrial plants. Additionally, it is involved in the metal based construction of buildings and building frames. Astra Industrial Group Company was incorporated in 1988 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Valuation
Title SAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||